Biorce
PrivateLast Round
Series A
Feb 2, 2026
Total Funding Raised
$61.56M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Biorce is a healthcare technology company that provides an AI-native clinical intelligence platform designed to accelerate and optimize clinical trial design, protocol development, and regulatory planning for pharmaceutical and biotechnology organizations.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biorce Comparables
Compare Biorce with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Intelligencia AI | 82% | |
| PhaseV | 77% | |
| QuantHealth | 76% |
Biorce Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 2, 2026 | ||||
| Seed | Jul 8, 2025 | ||||
| Seed | Nov 14, 2024 |
Key People
Founding team and executive leadership
Biorce Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DST Global | Series A |
| Mustard Seed Maze | Series A, Seed |
| Plug and Play Tech Center | Seed |
| Outsized Ventures | Seed |
| YZR Capital | Series A, Seed |
| Outsized Ventures | Seed |
| Norrsken VC | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
Grew 32% QoQ, from 149 to 197 employees.
- Aug 18, 2026
Grew 29% QoQ, from 136 to 175 employees.
Biorce Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biorce's valuation, stock price, and market status.
Is Biorce a public or private company?
Biorce is a private company.
What is the current stock price of Biorce?
Biorce is a private company, so its shares have no public market price. Caplight tracks Biorce's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biorce worth (valuation)?
Valuation information for Biorce is not publicly available.
Can I buy Biorce stock?
Biorce shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biorce's last funding round?
Biorce's most recent funding round was Series A on February 2, 2026.
Who are the main investors in Biorce?
Key investors in Biorce include DST Global, Mustard Seed Maze, YZR Capital, Norrsken VC, YZR Capital.
Will Biorce IPO soon?
No public IPO plans have been announced for Biorce.
How can I track Biorce secondary market activity?
Caplight tracks bids, offers, and trades in Biorce's shares on secondary markets.